arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

BioLife Solutions, Inc.

BLFS Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$38.61
0.0% Today
as of Oct 22, 16:46 ET
Last 30 days 0.00% Oct 07 → Oct 07
$37.61 $38.11 $38.61 $39.11 $39.61 Oct 07
Open
—
High
$38.83
Low
$36.96
Volume
—
Avg Vol
—
Mkt Cap
$1.9B
P/E (TTM)
41.07
Beta
—
52w High
$39.76
52w Low
$17.86
Div Yield
—
Shares Out
$49M

Recent Press Releases & News last 60 days · 4 items

Oct 6 · 14:28 MT Newswires
Repligen Closes BioLife Solutions Acquisition
Oct 6 · 13:05 PR GlobeNewswire
Repligen Completes Acquisition of BioLife Solutions
Oct 5 · 17:02 MarketBeat
BioLife Solutions Shareholders Approve Repligen Merger Agreement
▸ Show all 4 press releases & news Free account →

BLFS earnings at a glance

BioLife Solutions, Inc. (BLFS) is scheduled to report earnings on Thursday, November 5, 2026 — in 13 days. Analysts expect earnings per share of $0.01, compared with $0.04 in the same quarter last year (-75%). The options market is pricing a move of about ±13.4% after the report, a range of roughly $33.43 to $43.79 from today's $38.61. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.5% on average; after the most recent report on May 7, 2026 it moved +6.3%. That means options currently expect more movement than BLFS has typically delivered. BLFS beat the consensus EPS estimate in 4 of its last 4 reported quarters. Implied volatility is currently 86%. The share price of $38.61 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$18
$40
95% of range
Avg surprise (last 4)
+283.3%
Avg reaction (last 2)
+5.5%
100% positive
Latest IV / EM
86%
EM ±13.4% · $35 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.67$-0.28$0.12$0.52$0.91 Actual $-0.32Actual $-0.23Actual $-0.67Actual $-0.22Actual $-0.45Actual $-0.04Actual $0.04Est $-0.03Est $-0.02Actual $0.04Est $-0.01Actual $0.04Est $0.01Actual $0.91 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-16M$-38,700$16M$32M$47M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.91 — — — — financials
Thu May 7, 2026Mar/2026 $0.04 $0.01 +300.0% 0.0% +6.3% earnings
Thu Nov 6, 2025Sep/2025 $0.04 $-0.01 +500.0% — — earnings
Thu Aug 7, 2025Jun/2025 — $-0.02 +100.0% — — earnings
Thu May 8, 2025Mar/2025 $0.04 $-0.03 +233.3% — +4.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.04 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.45 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.22 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.67 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.23 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.32 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Nov 5, 2026Sep/2026OTHER $0.01$0.04 -75.0%

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$28M$28M—$28M$23M$22M—$21M
Cost of revenue$10M$10M——$8M$7M——
Gross profit$18M$17M——$15M$15M——
Operating income$2M$27,000—$-89,000$-16M$-499,000—$-418,000
Net income$45M$1M—$621,000$-16M$-448,000—$-2M
EPS (diluted)$0.91$0.02—$0.01$-0.33——$-0.04

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$24M$23M$33M$29M$32M$67M$95M$24M
Inventory$36M$33M$30M$28M$28M$28M$29M$32M
Total current assets$135M$133M$137M$127M$125M$131M$149M$89M
Total assets$447M$401M$406M$392M$387M$395M$399M$382M
Long-term debt$0$2M$5M$0$0$2M$5M$8M
Total liabilities$27M$29M$34M$38M$40M$43M$51M$56M
Total equity$420M$372M$372M$354M$347M$353M$349M$325M

Implied volatility — last 90 days

9%66%123%180%237% Jun 07 — IV 140% · EM ±19.3%Jun 08 — IV 118% · EM ±15.5%Jun 09 — IV 143% · EM ±18.0%Jun 10 — IV 151% · EM ±17.8%Jun 11 — IV 105% · EM ±11.6%Jun 12 — IV 131% · EM ±13.4%Jun 15 — IV 207% · EM ±15.0%Jun 16 — IV 218% · EM ±12.9%Jun 17 — IV 173% · EM ±7.2%Jun 19 — IV 71% · EM ±15.7%Jun 22 — IV 67% · EM ±14.0%Jun 23 — IV 53% · EM ±10.8%Jun 24 — IV 77% · EM ±15.3%Jun 25 — IV 81% · EM ±15.9%Jun 26 — IV 68% · EM ±13.1%Jun 29 — IV 84% · EM ±14.8%Jun 30 — IV 109% · EM ±18.8%Jul 01 — IV 105% · EM ±17.6%Jul 02 — IV 93% · EM ±15.1%Jul 03 — IV 97% · EM ±15.1%Jul 06 — IV 173% · EM ±23.9%Jul 07 — IV 155% · EM ±20.4%Jul 08 — IV 130% · EM ±16.3%Jul 09 — IV 150% · EM ±17.7%Jul 10 — IV 156% · EM ±17.2%Jul 13 — IV 226% · EM ±18.9%Jul 14 — IV 176% · EM ±12.7%Jul 15 — IV 216% · EM ±12.7%Jul 20 — IV 67% · EM ±15.8%Jul 21 — IV 62% · EM ±14.4%Jul 22 — IV 52% · EM ±11.8%Jul 23 — IV 42% · EM ±9.4%Jul 28 — IV 61% · EM ±12.5%Jul 29 — IV 49% · EM ±9.8%Jul 30 — IV 50% · EM ±9.8%Jul 31 — IV 51% · EM ±9.8%Aug 03 — IV 57% · EM ±10.1%Aug 04 — IV 52% · EM ±8.9%Aug 05 — IV 10% · EM ±1.6%Aug 11 — IV 18% · EM ±2.4%Aug 12 — IV 15% · EM ±1.9%Aug 20 — IV 133% · EM ±5.5%Aug 24 — IV 70% · EM ±14.7%Aug 25 — IV 70% · EM ±14.2%Aug 26 — IV 72% · EM ±14.3%Aug 27 — IV 73% · EM ±14.2%Aug 28 — IV 62% · EM ±11.8%Aug 31 — IV 72% · EM ±12.8%Sep 02 — IV 67% · EM ±11.3%Sep 03 — IV 60% · EM ±9.7%Sep 17 — IV 237% · EM ±9.9%Sep 21 — IV 70% · EM ±14.5%Sep 22 — IV 71% · EM ±14.6%Sep 23 — IV 69% · EM ±13.9%Sep 24 — IV 57% · EM ±11.3%Sep 25 — IV 59% · EM ±11.3%Oct 01 — IV 72% · EM ±11.7%Oct 02 — IV 86% · EM ±13.4%

Sector peers

AXGN
AxoGen, Inc.
$2.1B $36.68+1.4%
PRKS
United Parks & Resorts Inc.
$1.5B $31.08-2.1%
CNMD
CONMED Corporation
$1.3B $49.44+3.9%
TMDX
TransMedics Group, Inc.
$2.8B $72.06-3.6%
CBLL
CeriBell, Inc.
$901M $27.40-1.0%
INMD
INMODE LTD.
$805M $14.05-0.6%

BLFS earnings FAQ

When is BLFS's next earnings date?

BioLife Solutions, Inc. is expected to report on November 5, 2026.

What is BLFS's expected move for earnings?

Options currently price a move of about ±13.4%, or $5.18 per share either way from $38.61.

How does BLFS stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.5%, up 2 times and down 0 times.

What EPS are analysts expecting from BioLife Solutions, Inc.?

The consensus estimate is $0.01 per share, versus $0.04 a year ago.

What is BLFS's implied volatility?

BLFS's at-the-money implied volatility is about 86% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in